SAB reports progress with treatment for influenza
SAB Biotherapeutics is reporting promising news around its new treatment for the influenza virus.
SAB Biotherapeutics is reporting promising news around its new treatment for the influenza virus.
Sioux Falls-based SAB Biotherapeutics has released its first earnings report since becoming a publicly traded company.
A pair of Sioux Falls sisters — and Sanford nurses — created one of the first businesses in a new Sanford startup program, helping patients recover from heart surgery.
“The future is as big as you can imagine.” And they helped make it so. Meet the local couple behind this incredible startup success story.
Nonprofits formed within the past five years can pitch their concept at an event later this month to win $2,000.
Startup Sioux Falls will receive $1 million in federal funding to support entrepreneurship programming for underserved populations.
“We find that entrepreneurs have good ideas, but don’t know how to get their idea to the end user.” These boot camps are designed to help.
Sioux Falls-based SAB Biotherapeutics officially is a publicly traded company.
Query.AI, a startup founded in Brookings, has raised $15 million in new Series A financing for its unique cybersecurity product.
An investigational device invented at Sanford Health that helps high-risk vascular disease patients has been granted a breakthrough device designation by the U.S. Food and Drug Administration because it fills an unmet need.